生命科学初创公司mo:re获得230万欧元种子融资-动脉网

mo:re launches lab platform to set a new standard in animal-free drug development

D-Pharm 等信源发布 2025-03-27 12:58



可切换为仅中文







mo:re, a German Life Science startup, has raised €2.3 million in seed funding to accelerate the commercialization of its lab platform for complex cell culture workflows. High-Tech Gründerfonds (HTGF) led the round, with participation from Innovationsstarter Fonds Hamburg (IFH), Gilson Inc., NEDGEX, Nidobirds Ventures, and Private Investors R&R Medical and Martin Blüggel..

德国生命科学初创公司mo:re已经筹集了230万欧元的种子资金，以加速其用于复杂细胞培养工作流程的实验室平台的商业化。本轮融资由高科技创业基金（HTGF）领投，汉堡创新启动基金（IFH）、Gilson Inc.、NEDGEX、Nidobirds Ventures以及私人投资者R&R Medical和Martin Blüggel参与。

There is much agreement in the scientific community that organoids represent a significant step in the evolution to more representative disease modelling. The path to faster approval of more relevant drugs includes modern organoid models. This has been recognized by the FDA as well with their new guidelines clearing the path to replacing animal experiments with relevant organoid models.

科学界普遍认为，类器官代表着向更具代表性的疾病建模的重大进步。更相关的药物快速获批的路径中包括现代类器官模型。美国食品药品监督管理局（FDA）也认识到这一点，并发布了新指南，为用相关类器官模型取代动物实验铺平了道路。

The field is missing the means for broad application of organoids in higher throughput that achieves reproducible results in a standardized environment..

该领域缺少在更高通量下广泛应用类器官的手段，无法在标准化环境中取得可重复的结果。

mo:re has developed a groundbreaking lab platform, combining automation and software for planning, executing, and analysis of cell culture studies. The user-friendly platform aims to simplify cell culture, making organoids accessible as a standard lab technique and providing verifiable results. The lab automation device covers all relevant process steps, setting a new benchmark for scalability, reproducibility, and standardization of 3D cell culture models..

mo:re 开发了一个突破性的实验室平台，结合自动化和软件来进行细胞培养研究的规划、执行和分析。这个用户友好的平台旨在简化细胞培养，使类器官作为标准实验室技术变得触手可及，并提供可验证的结果。实验室自动化设备覆盖所有相关工艺步骤，为3D细胞培养模型的可扩展性、可重复性和标准化设立了新标杆。

“With this funding, we want to establish our presence in the market and continue building our team. Now it is time to focus our resources on developing further scientific applications to unlock the potential our platform has to offer together with our customers as well as our internal R&D lab”,

“通过这笔资金，我们希望在市场上建立自己的地位并继续组建我们的团队。现在是时候集中资源开发进一步的科学应用，以释放我们的平台与客户以及我们内部研发实验室共同提供的潜力。”

Lukas Gaats , CEO at mo:re.

卢卡斯·加茨，mo:re公司首席执行官。

“The Team of mo:re is poised to execute on its vision to provide easy access to a standardized way of performing 3D cell culture and obtain reproducible results for researchers worldwide”,

“mo:re团队准备执行其愿景，为全球研究人员提供标准化的3D细胞培养方式，并获取可重复的结果。”

Dr. Christian Kannemeier, Senior Investment Manager at HTGF.

HTGF高级投资经理克里斯蒂安·卡内迈尔博士。

“Our investment in mo:re reflects our confidence in their visionary product to tackle cell culture challenges. Their platform can redefine the landscape of non-animal methods in the Life Science Industry”,

“我们对mo:re的投资反映了我们对其前瞻性产品解决细胞培养挑战的信心。他们的平台可以重新定义生命科学行业中非动物方法的格局。”

Stefanie Höhn , Senior Investment Manager at IFH.

斯特凡妮·赫恩，IFH高级投资经理。

“Verifiable data in drug discovery and development are crucial for accelerating creation of new and effective pharmaceuticals. mo:re’s innovative technological approach provides an important step toward standardizing organoid growth, significantly enhancing their quality. This will not only improve the speed and reliability of drug discovery but also deliver more consistent results for research, ultimately reducing the reliance on animal testing,” .

“在药物发现和开发过程中，可验证的数据对于加速创造新的有效药物至关重要。mo:re的创新技术方法为标准化类器官生长提供了重要一步，显著提升了它们的质量。这不仅会提高药物发现的速度和可靠性，还会为研究提供更一致的结果，最终减少对动物试验的依赖。”

Dirk Freystadt, SVP Corporate Development at Gilson Inc.

Dirk Freystadt，Gilson Inc.公司企业发展高级副总裁

https://www.bionity.com/en/news/1185892/mo-re-launches-lab-platform-to-set-a-new-standard-in-animal-free-drug-development.html

https://www.bionity.com/zh/news/1185892/mo-re-launches-lab-platform-to-set-a-new-standard-in-animal-free-drug-development.html

A mini-heart in a Petri dish: organoid emulates the development of the human heart

培养皿中的迷你心脏：类器官模拟人类心脏的发育过程

New cell type discovered

发现新细胞类型

Read news

读新闻